Clinical Trials in Xi’an, China
Locations / Xi’an, China
Delta Trials records 2,464 clinical trials conducted in Xi’an, China, making it a notable site of clinical research activity. These trials across 2,003 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 83 trials in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Xi’an has changed over time.
2464
Total Trials
2003
Conditions
83
Terminated since 2020
Browse by condition (2003 total)
- Non-small cell lung cancer 69 trialsAll Non-small cell lung cancer trials
- Breast cancer 60 trialsAll Breast cancer trials
- Gastric cancer 41 trialsAll Gastric cancer trials
- Diabetes mellitus, type 2 34 trialsAll Diabetes mellitus, type 2 trials
- Coronary artery disease 29 trialsAll Coronary artery disease trials
- Asthma 26 trialsAll Asthma trials
- Hepatocellular carcinoma 26 trialsAll Hepatocellular carcinoma trials
- Carcinoma, non-small-cell lung 24 trialsAll Carcinoma, non-small-cell lung trials
- Hepatitis b, chronic 22 trialsAll Hepatitis b, chronic trials
- Type 2 diabetes mellitus 20 trialsAll Type 2 diabetes mellitus trials
- Stroke 17 trialsAll Stroke trials
- Schizophrenia 17 trialsAll Schizophrenia trials
- Heart failure 17 trialsAll Heart failure trials
- Helicobacter pylori infection 16 trialsAll Helicobacter pylori infection trials
- Depression 15 trialsAll Depression trials
- Acute coronary syndrome 15 trialsAll Acute coronary syndrome trials
- Multiple myeloma 15 trialsAll Multiple myeloma trials
- Liver cirrhosis 15 trialsAll Liver cirrhosis trials
- Obesity 14 trialsAll Obesity trials
- Prostate cancer 14 trialsAll Prostate cancer trials